跳到正文
FDA 官方药品与生物制品信息·精选AI 评分71

Greenwich Rx 因内毒素水平偏高自愿全国召回复配谷胱甘肽注射液

Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels

AI 导读

Greenwich Rx 于 2026 年 10 月 1 日宣布自愿全国召回其复配谷胱甘肽注射液至消费者层级,原因为可能存在内毒素水平偏高。涉及的 10 个批号为 200 mg/mL、10mL 多剂量瓶规格,标示用于皮下注射,使用期限在 2026 年 10 月 2 日至 11 月 12 日之间,产品于 2026 年 6 月 26 日至 9 月 21 日期间分销至全国。

推荐理由

材料列出召回批号、使用期限及企业所述风险,可供质量与供应链团队核对批次范围与消费者层级通知安排。

正文 · 原文

COMPANY ANNOUNCEMENT

When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company.

Read Announcement View Product Photos

Summary

Company Announcement Date:
October 01, 2026
FDA Publish Date:
October 01, 2026
Product Type:
Drugs
Reason for Announcement:

Recall Reason Description

Potential elevated endotoxin levels

Company Name:
Greenwich Rx
Brand Name:

Brand Name(s)

Greewich

Product Description:

Product Description

Glutathione Injection


Company Announcement

IMMEDIATE RELEASE - Tomball, Texas – October 1, 2026 – Greenwich Rx, a 503A compounding pharmacy, is voluntarily recalling specific lots of its compounded glutathione to the consumer level. The product is being recalled due to potential elevated endotoxin levels.

Risk Statement: There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death. To date, Greenwich Rx has received two reports involving patients who received emergency department care following intravenous (IV) administration of a glutathione product that was not formulated for IV use.

Glutathione is a naturally occurring antioxidant that helps protect cells from oxidative stress. The voluntary recall affects the following lots of compounded glutathione 200 mg/mL dispensed in 10mL multidose vials and intended for subcutaneous injection:

Product

Strength

Package Size

Lot Number

Beyond Use Date

Glutathione
Injection

200 mg/mL

10mL

0060-062426-1

10/02/2026

0060-062726-1

10/05/2026

0060-070926-1

10/17/2026

0060-071426-1

10/22/2026

0060-071426-2

10/22/2026

0060-072026-1

10/28/2026

0060-072726-1

11/04/2026

0060-072926-1

11/06/2026

0060-073126-1

11/08/2026

0060-080426-1

11/12/2026

The glutathione was distributed to patients nationwide between June 26, 2026, and September 21, 2026. Refer to the photo of the product label below for the location of lot number and beyond use date.

Greenwich Rx is notifying customers of this voluntary recall by mail. Customers who received glutathione from one of the recalled lots should stop using the product and follow the disposal instructions provided in the recall notification. Patients who believe they have experienced a health issue that may be related to the product should contact their healthcare provider.

Customers can direct questions regarding this recall to Sedgwick at (866) 552-4916 or GreenwichRx7542@sedgwick.com Monday through Friday between 8:00 AM to 5:00 PM Eastern Time.

Adverse reactions or quality problems experienced with the use of this product may also be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.


来源:FDA 官方药品与生物制品信息 · fda.gov